Business Wire

Thales Announces New Solutions to Help Organisations Discover, Protect and Control Sensitive Data in Multicloud Environments

Share

Thales today announced new data protection solutions for Google Cloud, Microsoft Azure, and Amazon Web Services, solidifying its role as a trusted third party for multicloud data security.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005282/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

© Thales

With each cloud provider having unique data protection mechanisms and key management offerings, multicloud data protection presents a complex security challenge for organisations. Thales’ latest cloud data security solutions allow customers to maintain control of and manage their encryption keys, as well as manage access and authentication across hybrid and multicloud environments.

“These capabilities are critical to cloud migration and security, especially with such accelerated growth in this area,” said Sunil Potti, Vice President and General Manager of Google Cloud Security. “True to our mission, we have forged this collaboration with Thales to further protect our customer’s most sensitive information. We are empowering customers to leverage the full potential of Google Cloud technology for sensitive workloads, by utilising the Customer-Managed Encryption Key-integrated GCP services, CipherTrust Cloud Key Manager and SafeNet Trusted Access for access management and authentication from Thales. This will enable enterprises to deal with a fluid and dynamic business environment where protecting sensitive data in the cloud is of extreme importance.”

Simplifying Multicloud Security

As customers look to reap the rewards from multicloud environments, Thales is making it easier to ensure protection against reputational risk and financial penalties arising from a cloud data breach. As such, customers will benefit from enhanced capabilities to Discover, Protect and Control sensitive data across multicloud environments, including the ability to:

Discover Sensitive Data in the Cloud and On-Premises

Thales Data Discovery and Classification automates the discovery, classification and protection of data in the cloud and on-premises using automation policies that identify sensitive data and protect the data with encryption or tokenisation. These capabilities have now been extended to the discovery and classification of data in Amazon Web Services S3 buckets and Azure Blob storage.

Protect Sensitive Data and Workloads in the Cloud

To address both the complexity of where data is stored and to help ensure data sovereignty in a multicloud environment, effective encryption and tokenisation is needed. Specific new data protection capabilities for cloud platforms include:

  • CipherTrust Transparent Encryption for advanced encryption and access controls, protects data in Amazon Web Services Simple Storage Service (S3)
  • Encryption of Kubernetes secrets and Google Anthos Service Mesh signing keys

Control Access to Applications and Sensitive Data in the Cloud

The accelerated adoption of encryption has led to the need to manage a far larger number of encryption keys across both traditional data stores and multicloud environments. Thales has enabled new capabilities that allow organisations to control access to data and ownership of their encryption keys, including:

  • Thales is also offering CipherTrust Cloud Key Manager support for Google Cloud’s External Key Manager (EKM), building on the existing CipherTrust Key Broker for Google Cloud EKM which is part of the Thales Data Protection on Demand cloud-based platform.

Secure and Protect access at the Login Point

Compromised identities pose one of the greatest risks for data breaches:

  • SafeNet Trusted Access integrates out of the box with Google Workspace, Azure and AWS, enforcing the appropriate access controls and authentication for privileged and regular users.
  • SafeNet Trusted Access is offering new abilities to provide authentication and authorisation for APIs and for applications not using industry-standard protocols such as SAML and OIDC.

“The proliferation of multicloud computing has created new organizational challenges in managing data across many different cloud environments. Whilst organisations have benefited from scalability and speed to market thanks to the power of cloud, the ever expanding IT cloud landscape has added greater complexity to data management and security,” said Sébastien Cano, Senior Vice President, Cloud Protection and Licensing activities at Thales.“In a post pandemic, highly regulated world, it is even more important for organisations to understand what data they have, where it sits, who can access it and the risks associated with managing it. Only once an organization understands all of these data lifecycle aspects, can they ensure that it is secured and managed correctly.”

Additional Resources

Thales and Google Cloud have forged a strong collaboration to help enterprises migrate sensitive data between public cloud, hybrid and private IT infrastructures. Watch this video with Sunil Potti, VP and GM at Google Cloud Security to learn more.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.

Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.

Thales Group
Security

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS
Thales, Media Relations
Security
Constance Arnoux
+33 (0)6 44 12 16 35
constance.arnoux@thalesgroup.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Leading Liver Disease Researchers Present at EASL International Liver Congress™ 2021, Demonstrate Prognostic Value of Echosens’ FibroScan-based Agile Scores for Patients with Liver Disease23.6.2021 14:53:00 CEST | Press release

Echosens, a high-technology company offering the FibroScan family of products, today announces that distinguished researchers will present studies supporting the value of FibroScan at EASL’s International Liver Congress, June 23-26, 2021. An area of focus will be FibroScan-based Agile scores to easily detect advanced fibrosis and cirrhosis in non-alcoholic fatty liver disease (NAFLD) patients. “Agile scores were built on a large and global pool of patient data and have been externally validated on two large cohorts of patients—one from France and one from the United States—to achieve this exceptional level of score development,” says Dominique Legros, Group CEO, Echosens. “These novel, noninvasive scores reduce the number of false positive cases compared to liver stiffness measurement (LSM) by vibration controlled transient elastography (VCTE™) alone, accurately predict liver complications and, in coming years, will identify patients eligible for pharmaceutical treatments.” Currently a

Sherlock Biosciences’ 221b Foundation Enables Global Access to COVID-19 Diagnostics with Up To 10 Million Tests Per Month23.6.2021 14:30:00 CEST | Press release

The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that its partnerships will increase COVID-19 diagnostic manufacturing capacity by up to 10 million tests per month by year-end. Through multiple license agreements this year with organizations including ALBOT Technologies, Cooper International, LogicInk, Rokline, United PPE and binx health, The 221b Foundation has enabled manufacturing and global distribution in the U.S., United Arab Emirates, India and Singapore, and is in discussions to expand beyond these geographies to increase access for vital diagnostic solutions around the world. The 221b Foundation was founded to aid in the fight against the global COVID-19 pandemic by enabling access to intellectual property associated with the company’s SHERLOCK™ CRISPR-based technology. Proceeds from third-party sales of SHERLOCK CRISPR COVID-19 products have

Offer Document in Respect of the Recommended Cash Offer to the Shareholders of Adapteo Plc Made Public23.6.2021 14:00:00 CEST | Press release

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden or Finland who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this announcement and in the offer document. Shareholders in the United States should also refer to the section titled “Special notice to shareholders in the United States” at the end of this announcement and in the offer document. On 17 May 2021, Palace Bidco Oy (“WSIP Bidco”), a private limited liability company formed on behalf of, and indirectly wholly owned by, West Street Global Infrastructure Partne

Druva Launches Industry’s First MSP Program with the Simplicity, Security, and Scale of a SaaS Platform23.6.2021 14:00:00 CEST | Press release

Druva Inc., the leader in Cloud Data Protection and Management, today announced the launch of its new Managed Service Provider (MSP) program. Part of the Druva Compass Partner Program, the new program is designed to empower MSPs and accelerate their customers’ cloud transformation with a resilient, simplified data protection service. Over the last 12 months, enterprises have accelerated and expanded the shift of operations to the cloud and according to a recent survey by Gartner, Inc., 68 percent of global respondents indicate that their organizations plan to increase spending on cloud computing in the next year.* MSPs are increasingly relied upon to help customers navigate these challenges, reduce operational complexity, and eliminate costly hardware. However, current data protection offerings demand significant infrastructure, requiring MSPs to make capital investments, manage complex environments, delay sales cycles, and compress operational margins. “Customers are moving to the clo

Sintavia Hires Brian Haggenmiller as Chief Financial Officer23.6.2021 13:59:00 CEST | Press release

Sintavia, LLC, a designer and 3D printer of a new generation of flight and launch components, announced today that it had hired Brian Haggenmiller as its new Chief Financial Officer. Mr. Haggenmiller had previously been the Senior Director of Financial Planning & Analysis at AerSale Corp., where he led that company’s financial planning efforts in advance of it going public in 2020 via a special purpose acquisition company. While at AerSale, Mr. Haggenmiller was also responsible for evaluating all types of commercial aerospace transactions, ranging from single engine deals to multiple aircraft packages. Mr. Haggenmiller holds a B.S. in Business Administration from Washington University’s Olin School of Business, and a Master of Business Administration from the University of Miami School of Business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210623005345/en/ (Photo: Business Wire) “We could not be more excited to have Bri

Chiesi Accelerates Path Toward Full Sustainability Despite Covid-19 Pandemic23.6.2021 13:39:00 CEST | Press release

Chiesi, the international research-focused pharmaceutical and healthcare Group (Chiesi Group), further accelerated its path toward becoming a fully sustainable company, despite an extremely challenging 2020, which was overshadowed by the Covid-19 pandemic. This is the thread running through Chiesi’s Annual & Sustainability Report 2020. The Group in 2020 turned in a robust financial performance, with revenues amounting to €2,229 million, up by 11.8% compared to 2019. It provides Chiesi with impetus to continue its transformational journey to become the world’s first fully sustainable pharmaceutical company, in which value generation for the planet and for society enables the creation of innovation, progress and prosperity. Transparent impact measurement methodology that integrates ESG (environmental, social, and corporate governance) topics and impact frameworks As in previous years, Chiesi is reporting how it operates in accordance with a comprehensive combination of multiple tools and

Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 202123.6.2021 13:00:00 CEST | Press release

Brii Biosciences (“Brii Bio”) and VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), today announced final results from a Phase 1b/2a study on BRII-179 (VBI-2601), a novel recombinant, protein-based immunotherapeutic candidate, in patients with chronic hepatitis B virus (HBV) infection. Data from the study, which evaluated the safety, antiviral activity, and immunogenicity of BRII-179 (VBI-2601) alone or admixed with interferon-alpha (IFN-α) as co-adjuvant, demonstrated that the investigational immunotherapeutic induced both B cell (antibody) and T cell responses, and was well-tolerated with no safety signals observed, in non-cirrhotic chronic hepatitis B patients under nucleos(t)ide analog (NUC) therapy. The study was led by Brii Bio in partnership with VBI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210623005322/en/ The data, as presented in a late-breaker e-Poster at the European Association for the Study of the Liver’s (EASL)

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom